Salem Investment Counselors Inc Invitae Corp Transaction History

Salem Investment Counselors Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 04, 2023	SELL	$0.6 - $1.53 $1,020 - $2,601	-1,700 Reduced 70.83%	700 $0
Q2 2023 Jul 19, 2023	SELL	$1.05 - $1.63 $945 - $1,467	-900 Reduced 27.27%	2,400 $2,000
Q1 2023 May 11, 2023	SELL	$1.2 - $2.73 $720 - $1,638	-600 Reduced 15.38%	3,300 $4,000
Q3 2022 Nov 09, 2022	SELL	$1.9 - $8.63 $5,177 - $23,516	-2,725 Reduced 41.13%	3,900 $10,000
Q2 2022 Aug 17, 2022	SELL	$2.13 - $9.01 $225 - $955	-106 Reduced 1.57%	6,625 $16,000
Q1 2022 May 16, 2022	BUY	$6.28 - $15.59 $6,788 - $16,852	1,081 Added 19.13%	6,731 $54,000
Q4 2021 Feb 15, 2022	BUY	$14.7 - $28.67 $76,660 - $149,514	5,215 Added 1198.85%	5,650 $86,000
Q3 2021 Nov 15, 2021	BUY	$24.31 - $33.6 $10,574 - $14,616	435 New	435 $12,000

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Salem Investment Counselors Inc, based on Form 13F filings with the SEC.

Stay updated on Salem Investment Counselors Inc with notifications on news.